Sophie de Guibert

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 726 citations · Full text

Medicine, Hematology, Oncology +12

Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories

Régis Peffault de Latour, Jean Yves Mary, Célia Salanoubat et al. · Blood · 2008 · 375 citations

Medicine, Hematology, Hematopathology +10

Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study

Gilles Salles, Nicolas Mounier, Sophie de Guibert et al. · Blood · 2008 · 331 citations

Medicine, Hematology, Oncology +11

Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria

Richard J. Kelly, Britta Höchsmann, Jeff Szer et al. · New England Journal of Medicine · 2015 · 275 citations · Full text

Life Sciences, Hematology, Pharmacotherapy +17

Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma

Olalekan O. Oluwole, Krimo Bouabdallah, Javier Muñoz et al. · British Journal of Haematology · 2021 · 214 citations · Full text

Medicine, Oncology, Pharmacotherapy +17